A Study of BBP-711 (ORF-229) in Healthy Adult Volunteers
Clinical trial NCT04876924 · COMPLETED
Trial details
- NCT number
- NCT04876924
- Sponsor
- Cantero Therapeutics, a BridgeBio company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2022-02-27
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.